Malihe Pooresmaeil
Overview
Explore the profile of Malihe Pooresmaeil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
141
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alizadeh M, Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2025 Feb;
304(Pt 2):140912.
PMID: 39947559
Researching the potential of various composite materials to remove water pollutants is an important issue for scientists, and polysaccharides are considered desirable materials in this field. Despite the unique advantages,...
2.
Safarpour R, Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2024 Nov;
282(Pt 2):137096.
PMID: 39486742
Considering the benefits of controlled drug delivery in cancer treatment, as well as the importance of biological macromolecules in this area, herein, the pre-synthesized carboxymethyl starch (CMS) was converted to...
3.
Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2024 Apr;
268(Pt 1):131590.
PMID: 38621563
This work aimed to prepare a new system for daunorubicin (DNR) delivery to improve therapeutic efficiency and decrease unwanted side effects. Typically, at first, a carboxylic acid functional group containing...
4.
Javanbakht S, Darvishi S, Dorchei F, Hosseini-Ghalehno M, Dehghani M, Pooresmaeil M, et al.
ACS Omega
. 2023 Sep;
8(37):33202-33228.
PMID: 37744789
Diabetes mellitus is a prevalent chronic health condition that has caused millions of deaths worldwide. Monitoring blood glucose levels is crucial in diabetes management, aiding in clinical decision making and...
5.
Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2023 Apr;
239:124322.
PMID: 37019202
To develop a new more efficient colon cancer treatment bio-vehicle, in frontier research, for the first time, an attempt has been made to design a unique colon-targeted bio-carrier containing polysaccharides...
6.
Alizadeh M, Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2023 Feb;
234:123778.
PMID: 36822289
In recent years, the fabrication of new drug delivery systems (DDSs) based on functionalization by multi-component reactions (MCRs) has received special attention. In this regard, to obtain a new oral...
7.
Hassanpouraghdam Y, Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2022 Sep;
221:256-267.
PMID: 36067851
Herein, for the first time, the photoluminescent graphene quantum dots@Bio-metal organic framework (GQDs@Bio-MOF) nanohybrid was prepared. BET analysis obtained the average pore diameter of GQDs@Bio-MOF about 11.97 nm. The existence...
8.
Pooresmaeil M, Namazi H
Int J Pharm
. 2022 Aug;
625:122112.
PMID: 35970281
Commonly the directly administered chemotherapy drugs lack targeting in tumor treatment. Thus, trying to improve cancer treatment efficiency led us to design a new intelligent system for cancer treatment. Considering...
9.
Pooresmaeil M, Namazi H
Int J Biol Macromol
. 2022 Jan;
200:247-262.
PMID: 35007630
This work aimed to fabricate a new photoluminescent bionanogel with both targeted anticancer drug delivery and bioimaging potentials. Briefly, at first photoluminescent carbon dots (CDs) were synthesized from the low-cost...
10.
Ranjbar E, Namazi H, Pooresmaeil M
Int J Biol Macromol
. 2022 Jan;
201:193-202.
PMID: 35007629
Achieving a new oral drug delivery system with controlled drug release behavior is valuable in cancer therapy. Therefore, for the first time, doxorubicin (DOX) and 5-fluorouracil (5-Fu) were simultaneously co-loaded...